Loading...
Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity
Doxorubicin (DOX) is a well-known chemotherapeutic agent extensively applied in the field of cancer therapy. However, similar to other chemotherapeutic agents such as cisplatin, paclitaxel, docetaxel, etoposide and oxaliplatin, cancer cells are able to obtain chemoresistance that limits DOX efficacy...
Na minha lista:
| Udgivet i: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7697177/ https://ncbi.nlm.nih.gov/pubmed/33187385 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12111084 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|